Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

600 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Completed

Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds

NCT00486278

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Augusta, Georgia, United States
  • Novo Nordisk Investigational Site Chicago, Illinois, United States
  • Novo Nordisk Investigational Site Indianapolis, Indiana, United States
View all 45 locations
View Trial Details
Completed

Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects

NCT00837356

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Berlin, Germany
  • Novo Nordisk Investigational Site Hanover, Germany
  • Novo Nordisk Investigational Site Tel Litwinsky, Israel
  • Novo Nordisk Investigational Site Florence, Italy
View Trial Details
Completed

Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients

NCT00914459

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Kuopio University Hospital Kuopio, Finland
  • LTD Medinvesti- Institute of hematology and transfusiology Tbilisi, Georgia
  • Centro di Riferimento Regionale per la cura dell'Emofilia e delle Malattie Emorragiche Congenite Parma, Italy
  • Spitalul Clinic Judetean de Urgenta Craiova Craiova, Dolj, Romania
View all 17 locations
View Trial Details
Completed

Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A

NCT01692925

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Berlin, Germany
  • Novo Nordisk Investigational Site Frankfurt/M., Germany
  • Novo Nordisk Investigational Site Riga, Latvia
  • Novo Nordisk Investigational Site Kuala Lumpur, Malaysia
View Trial Details
Completed

Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A

NCT01205724

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Iowa City, Iowa, United States
  • Novo Nordisk Investigational Site Lexington, Kentucky, United States
  • Novo Nordisk Investigational Site Baltimore, Maryland, United States
  • Novo Nordisk Investigational Site Philadelphia, Pennsylvania, United States
View all 18 locations
View Trial Details
Completed

A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543

NCT01238367

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Itabashi-ku, Tokyo, Japan
  • Novo Nordisk Investigational Site Kashihara-shi, Nara, Japan
  • Novo Nordisk Investigational Site Maebashi-shi, Gunma, Japan
  • Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan
View Trial Details

Related conditions